IO Biotech, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 34.1% | 34.1% | -213.0% |
| FY2021 | -32.0% | -32.0% | -30.5% |
| FY2022 | -51.5% | -51.5% | -47.1% |
| FY2023 | -64.6% | -64.6% | -57.1% |
| FY2024 | -203.1% | -203.1% | -141.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 34.1% | 34.1% | -213.0% |
| FY2021 | -32.0% | -32.0% | -30.5% |
| FY2022 | -51.5% | -51.5% | -47.1% |
| FY2023 | -64.6% | -64.6% | -57.1% |
| FY2024 | -203.1% | -203.1% | -141.1% |